Stem Cells - Engineering Stem Cells to Evade Immune Rejection |
|
|
|
|
|
The latest stem cells news from News Medical |
|
|
|
| |
Solutions for iPSCs Culturing
Unlock the full potential of human induced pluripotent stem cells (iPSCs) for cutting-edge cell therapy. iPSCs offer unlimited self-renewal and the capacity to be genetically engineered, allowing customized immune cell production ranging from T cells, NK cells to Macrophages. ACROBio's toolkits, which include IL-3, IL-7, IL-15, DLL4, Flt-3L, and laminin matrix proteins, support your iPSC culture and differentiation at every stage. Overcome cell therapy challenges with iPSC-derived immune cells, and help shape the future of allogenic "off-the-shelf" cell therapy.
| |
|
|
| | | | Cancer stem cells cause the aging of macrophages in mice with healthy immune systems, creating conditions for the formation of tumors. | | | | Cell and organ transplants can be lifesaving, but patients often encounter long waiting lists due to the shortage of suitable donors. | | | | Cell therapy represents a potential regenerative treatment for osteoarthritis. | | | | Mortality related to end stage liver disease is ranked as the 12th most common cause of death in the U.S. Liver transplantation remains the only treatment for end stage liver disease, but there is a critical shortage of organ donors, necessitating a dire need for new forms of treatment. | | | | Heart rates are easier to monitor today than ever before. Thanks to smartwatches that can sense a pulse, all it takes is a quick flip of the wrist to check your heart. | |
|
|
| | | How would you rate today's newsletter?
| |
|
|
|
|
|
|